231 results
Page 2 of 12
6-K
EX-99
3aqmkyckohln2kkbam
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-99
cprf79bog667v x6
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-99
a5vas0xc
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-99
f25cqrp59fpotsyat
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
7ka hysia0ao
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
i4gfwgfx
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-99
cvluglhb0t2uwkq6u
27 Sep 22
BioLineRx Announces U.S. Commercialization Plan for APHEXDA (Motixafortide) in Stem Cell Mobilization
7:00am
6-K
EX-5.2
a3rc1rq8k
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.3
3766iul8wnnh6g5car
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.2
jkknezduq 00ly3
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
k1xw79ebbg
21 Sep 22
Current report (foreign)
8:00am
424B5
986zjc
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
21n dihw339
15 Sep 22
Current report (foreign)
8:39am
20-F/A
EX-15.1
uwxtqd5ryuqqg7nm2r
9 Sep 22
Annual report (foreign) (amended)
4:15pm
20-F/A
fmvss ojn
9 Sep 22
Annual report (foreign) (amended)
4:15pm
6-K
EX-99
ivrn6 qjdwsld6jqh
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
pw886qzttzvhimqqbc7
5 Jul 22
Current report (foreign)
6:02am
6-K
EX-99
jtxeua3 usrg
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
92ai 7ekja6ogvm
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
vcbxcd
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm